Cryptotanshinone

Cryptotanshinone is a diterpenoid compound extracted from Salvia miltiorrhiza that demonstrates potent anti-cancer properties through multiple pathway inhibitions. This bioactive compound exhibits cytotoxic effects against lung and ovarian cancer cells while providing anti-inflammatory benefits.

Origin & History

Cryptotanshinone is a heterocyclic diterpenoid quinone (C₁₉H₂₀O₃) naturally extracted from the roots of Salvia miltiorrhiza (danshen), a traditional Chinese medicinal herb. The compound appears as orange to orange-brown needle-like crystals with a melting point of 192°C and is produced through extraction and purification from the dried root material.

Historical & Cultural Context

Cryptotanshinone is a bioactive constituent of danshen (Salvia miltiorrhiza), a foundational herb in traditional Chinese medicine used for centuries to treat cardiovascular conditions, inflammation, and blood stasis-related disorders. The compound represents one of the key constituents responsible for danshen's traditional therapeutic properties.

Health Benefits

• Anti-cancer properties: Demonstrates cytotoxic effects against lung cancer (A549, IC50 1.27 μg/mL) and ovarian cancer cells (TOV-21G, IC50 1.39 μg/mL) through multiple pathway inhibitions (preliminary evidence from in vitro studies)
• Anti-inflammatory effects: Exhibits anti-inflammatory activity through STAT3 signaling pathway inhibition (mechanism-based evidence)
• Antimicrobial activity: Shows antibacterial effects against Staphylococcus aureus strains (preliminary in vitro evidence)
• Cardiovascular support: As a constituent of danshen, traditionally used for cardiovascular conditions, though specific clinical evidence not provided
• Antioxidant properties: Demonstrates antioxidant activity (mechanism described but clinical evidence not provided)

How It Works

Cryptotanshinone exerts its anti-cancer effects by inhibiting multiple cellular pathways involved in tumor growth and proliferation. The compound demonstrates cytotoxic activity through apoptosis induction and cell cycle arrest mechanisms. Its anti-inflammatory properties likely involve modulation of pro-inflammatory mediator pathways, though specific molecular targets require further investigation.

Scientific Research

The available research does not include human clinical trials, randomized controlled trials, or meta-analyses with PubMed PMIDs. Current evidence is limited to in vitro cytotoxicity studies showing IC50 values of 1.27 μg/mL in A549 lung cancer cells and 1.39 μg/mL in TOV-21G ovarian cancer cells, along with mechanistic pathway studies.

Clinical Summary

Current research on cryptotanshinone is primarily limited to in vitro laboratory studies. Cell culture experiments show significant cytotoxic effects against A549 lung cancer cells (IC50 1.27 μg/mL) and TOV-21G ovarian cancer cells (IC50 1.39 μg/mL). Anti-inflammatory activity has been demonstrated in laboratory studies, but specific quantified outcomes are not well-established. No human clinical trials have been conducted to confirm these preliminary findings or establish therapeutic dosages.

Nutritional Profile

Cryptotanshinone is a pure bioactive abietane-type diterpene quinone compound (molecular formula: C19H20O3, molecular weight: 312.36 g/mol), isolated primarily from the roots of Salvia miltiorrhiza (Danshen). It is not a food ingredient and therefore carries no conventional macronutrient or micronutrient profile (zero protein, carbohydrate, fat, fiber, or caloric value in physiological nutritional terms). As a concentrated phytochemical compound, it is characterized entirely by its bioactive properties: it belongs to the tanshinone family of lipophilic polycyclic diterpenoids, sharing a fused tricyclic or tetracyclic ring system. Typical extraction yields from Danshen root range from 0.01% to 0.05% dry weight. Bioavailability is notably limited due to its poor water solubility (log P approximately 3.5, indicating high lipophilicity), which restricts oral absorption; studies suggest first-pass metabolism significantly reduces systemic bioavailability, with peak plasma concentrations achieved more effectively via lipid-based or nanoparticle formulation systems. It is metabolized hepatically via CYP450 enzymes (notably CYP1A2 and CYP3A4). No dietary reference intakes exist; experimental doses in preclinical studies typically range from 5 to 40 mg/kg body weight. No vitamins, minerals, or fiber content is applicable to this pure isolated compound.

Preparation & Dosage

No clinically studied dosage ranges for cryptotanshinone in human subjects are available in the current research. Standardized extract concentrations and dosage recommendations for different formulations have not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Tanshinone IIA, other danshen compounds, antioxidants, anti-inflammatory herbs, cardiovascular support nutrients

Safety & Interactions

Safety data for cryptotanshinone supplementation in humans is extremely limited due to lack of clinical studies. Potential side effects, appropriate dosage ranges, and contraindications have not been established through human research. Drug interactions remain unknown and could potentially affect medications metabolized through similar pathways. Pregnant and breastfeeding women should avoid cryptotanshinone supplements due to insufficient safety data and potential hormonal effects.